semaglutide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣ ⁣ Read the full SURPASS-CVOT results and Research Summary SELECT Cardiovascular Trial Information |

Audrey Calderwood, MD, director of the GI Cancer Risk and Prevention Clinic at the Dartmouth Geisel School of Medicine in Hanover, New Hampshire, and an ASGE member, notes however that a low-residue diet may be an option instead of a liquid diet

Read More News Press Release Jan 22, 2026 New RAND Study Shows U.S

Bumping up the thermostat by 1 degree Fahrenheit (0.6 degrees Celsius) yields about a 3% savings in cooling costs, said Patrick Phelan, mechanical engineering professor at Arizona State University

Ive been running this program for six years now, and the results from participants after just two weeks continues to amaze me